Marinus Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company dedicated to the development of ganaxolone, which offers a new mechanism of action, an extensive safety database, and convenient dosing to improve the lives of patients suffering from drug-resistant seizures and neuropsychiatric disorders.


Clinical Trials

Physicians and patients learn more about ganaxolone and Marinus Pharmaceuticals’ clinical trials here.

View Pipeline >

Follow Us on Twitter

Titan V's Twitter avatar
Titan V

@CDKL5UK Hoping for swift action from FDA on @MarinusPharma CDKL5 treatment. t.co/KJ7qGj7le2 t.co/eujnsfx0eR

Retweeted by Marinus Pharma
Show Media
Tweet Media